Bulk Peptide Supply
10 mg vial
- Vendor score
- 84/100
- Effective vial price
- Not available
- Effective price per mg
- Not available
Survodutide is commonly sold or discussed for appetite, weight management, glucose control, and metabolic research.
Also known as survodutide
Historical market context
Historical market low and median per mg across recorded offers. These market summaries are separate from our exact-product comparisons.
History updated Sep 21, 2026. Vendor coverage, package sizes, product forms and promotions can vary over time. Use exact-product comparisons for current listed prices; historical market prices do not establish vendor trust.
| Date | Low /mg | Median /mg | Vendors | Offers |
|---|---|---|---|---|
| $3.78 | $8.82 | 15 | 17 | |
| $3.78 | $8.82 | 15 | 17 | |
| $3.78 | $8.55 | 15 | 17 | |
| $3.78 | $8.55 | 15 | 17 | |
| $3.78 | $8.82 | 15 | 17 | |
| $3.78 | $8.95 | 13 | 14 | |
| $3.78 | $8.95 | 13 | 14 | |
| $3.78 | $8.95 | 13 | 14 | |
| $3.78 | $8.95 | 13 | 14 | |
| $3.78 | $8.95 | 13 | 14 | |
| $3.78 | $8.95 | 13 | 14 | |
| $3.78 | $8.95 | 13 | 14 | |
| $3.78 | $8.95 | 13 | 14 | |
| $3.78 | $8.95 | 13 | 14 | |
| $3.78 | $8.95 | 13 | 14 | |
| $3.78 | $8.95 | 13 | 14 | |
| $3.78 | $8.95 | 13 | 14 | |
| $3.78 | $8.95 | 13 | 14 | |
| $3.78 | $8.95 | 13 | 14 | |
| $3.78 | $9.00 | 12 | 13 | |
| $3.78 | $9.00 | 12 | 13 | |
| $3.78 | $9.00 | 12 | 13 | |
| $3.78 | $9.00 | 12 | 13 | |
| $3.78 | $10.00 | 13 | 14 | |
| $3.78 | $10.00 | 13 | 14 | |
| $3.78 | $10.00 | 13 | 14 | |
| $3.78 | $10.00 | 13 | 14 | |
| $3.78 | $10.00 | 13 | 14 | |
| $3.78 | $10.00 | 13 | 14 | |
| $3.78 | $10.00 | 13 | 14 | |
| $3.78 | $10.00 | 13 | 14 | |
| $3.78 | $10.00 | 13 | 14 | |
| $3.78 | $10.00 | 13 | 14 | |
| $3.78 | $10.00 | 13 | 14 | |
| $3.78 | $10.00 | 13 | 14 | |
| $3.78 | $10.00 | 13 | 14 | |
| $3.78 | $10.00 | 13 | 14 | |
| $3.78 | $10.00 | 13 | 14 | |
| $3.78 | $10.00 | 13 | 14 | |
| $3.78 | $10.00 | 13 | 14 | |
| $3.78 | $10.00 | 13 | 14 | |
| $3.78 | $10.00 | 13 | 14 | |
| $3.78 | $11.00 | 12 | 13 | |
| $7.02 | $11.71 | 11 | 12 | |
| $7.02 | $11.71 | 11 | 12 | |
| $7.02 | $11.71 | 11 | 12 | |
| $7.02 | $11.71 | 11 | 12 | |
| $7.02 | $11.71 | 11 | 12 | |
| $7.02 | $11.71 | 11 | 12 | |
| $7.02 | $11.71 | 11 | 12 | |
| $7.02 | $12.42 | 10 | 11 | |
| $7.02 | $12.42 | 10 | 11 | |
| $7.02 | $12.42 | 10 | 11 | |
| $7.02 | $12.42 | 10 | 11 | |
| $7.02 | $12.42 | 10 | 11 | |
| $7.02 | $12.42 | 10 | 11 | |
| $7.02 | $12.42 | 10 | 11 | |
| $7.02 | $13.36 | 9 | 10 | |
| $7.02 | $14.31 | 7 | 7 | |
| $7.02 | $14.31 | 7 | 7 | |
| $7.02 | $14.31 | 7 | 7 | |
| $7.02 | $14.31 | 7 | 7 | |
| $7.02 | $14.31 | 7 | 7 | |
| $7.02 | $14.31 | 7 | 7 | |
| $7.02 | $14.65 | 8 | 8 | |
| $7.02 | $11.65 | 6 | 6 | |
| $7.02 | $11.65 | 6 | 6 | |
| $7.02 | $11.65 | 6 | 6 | |
| $7.02 | $11.65 | 6 | 6 | |
| $7.02 | $11.65 | 6 | 6 | |
| $7.02 | $11.65 | 6 | 6 | |
| $7.02 | $11.65 | 6 | 6 | |
| $7.02 | $11.65 | 6 | 6 | |
| $7.02 | $11.65 | 6 | 6 | |
| $7.02 | $11.65 | 6 | 6 | |
| $7.02 | $11.65 | 6 | 6 | |
| $7.02 | $11.65 | 6 | 6 | |
| $7.02 | $11.65 | 6 | 6 | |
| $7.02 | $11.65 | 6 | 6 | |
| $7.02 | $11.65 | 6 | 6 | |
| $7.02 | $11.65 | 6 | 6 | |
| $7.02 | $11.65 | 6 | 6 | |
| $7.02 | $11.65 | 6 | 6 | |
| $7.02 | $11.65 | 6 | 6 | |
| $7.02 | $11.65 | 6 | 6 | |
| $7.02 | $11.65 | 6 | 6 | |
| $7.02 | $11.65 | 6 | 6 | |
| $7.02 | $11.65 | 6 | 6 | |
| $8.55 | $14.31 | 5 | 5 | |
| $7.02 | $11.65 | 6 | 6 | |
| $7.02 | $11.65 | 6 | 6 | |
| $7.02 | $11.65 | 6 | 6 | |
| $7.02 | $12.15 | 6 | 6 | |
| $7.02 | $12.15 | 6 | 6 | |
| $7.02 | $10.00 | 5 | 5 | |
| $7.02 | $10.00 | 5 | 5 | |
| $2.38 | $8.51 | 4 | 4 | |
| $2.38 | $8.51 | 4 | 4 | |
| $2.38 | $8.51 | 4 | 4 | |
| $7.02 | $8.51 | 2 | 2 | |
| $7.02 | $8.51 | 2 | 2 | |
| $7.02 | $8.51 | 2 | 2 | |
| $7.02 | $8.51 | 2 | 2 | |
| $7.02 | $8.51 | 2 | 2 | |
| $7.02 | $10.00 | 4 | 4 | |
| $7.02 | $10.00 | 4 | 4 | |
| $7.02 | $8.51 | 2 | 2 | |
| $7.02 | $7.02 | 1 | 1 |
Research shortlist · Sep 12, 2026
These research selections use the same basis: 10 mg vial. The selections remain from Sep 12, 2026; each price below comes from its dated market observation.
10 mg vial
10 mg vial
10 mg vial
What it is
Survodutide is under investigation in clinical trial NCT06077864 (A Study to Test the Effect of Survodutide (BI 456906) on Cardiovascular Safety in People With Overweight or Obesity (SYNCHRONIZE™ - CVOT)). The listed molecular formula is C192H289N47O61. PepGrades separately preserves the catalog category because a chemical identity record does not establish a use, outcome, or product quality.
This label describes the available research record, not whether the compound is safe or effective for an individual.
Research context
5 registered studies were found under this name in the current review. Each study still needs to be checked for the exact compound identity, population, endpoints, and results.
Search indexed research for this compound ↗Market context
Survodutide is commonly sold or discussed for appetite, weight management, glucose control, and metabolic research. That describes market demand, not proof that the compound is safe or effective.
Market demand and online discussion do not establish product quality, safety, or effectiveness.Same format. Same amount.
1 of 1 formats had a qualifying research shortlist on Sep 12, 2026. Vendor counts below reflect the available price observations.
Vendor directory
Grades describe the vendor record overall. They are not a test result for every product.
| Vendor | Grade | Compared offers | In stock when checked | Lowest effective package | Profile |
|---|---|---|---|---|---|
| EZ PeptidesVendor grade | Grade A- | 1 | 1 | $70.20Automatic buy x get y free · listed $7810 mg vial · compare →Observed Sep 21, 2026 | View → |
| Polaris PeptidesVendor grade | Grade A- | Not available | Not available | Not availableNo market observation | View → |
| Orbitrex PeptidesVendor grade | Grade A- | 1 | 1 | $99.9910 mg vial · compare →Observed Sep 21, 2026 | View → |
| Bulk Peptide SupplyVendor grade | Grade B+ | Not available | Not available | Not availableNo market observation | View → |
| Ameano PeptidesVendor grade | Grade B+ | 1 | 1 | $9510 mg vial · compare →Observed Sep 21, 2026 | View → |
| Paramount PeptidesVendor grade | Grade B | Not available | Not available | Not availableNo market observation | View → |
| RUOVendor grade | Grade B | Not available | Not available | Not availableNo market observation | View → |
| Nationwide PeptidesVendor grade | Grade B+ | Not available | Not available | Not availableNo market observation | View → |
| PeptidologyVendor grade | Grade C | Not available | Not available | Not availableNo market observation | View → |
| Nuscience PeptidesNot enough information to grade | Not enough information to grade | Not available | Not available | Not availableNo market observation | View → |
| Skye PeptidesNot enough information to grade | Not enough information to grade | Not available | Not available | Not availableNo market observation | View → |
| TydesNot enough information to grade | Not enough information to grade | Not available | Not available | Not availableNo market observation | View → |
Sources and review
Last editorial review: Aug 30, 2026. Sources support the compound guide only and do not affect vendor grades.